Literature DB >> 26131067

Local delivery of rhVEGF165 through biocoated nHA/coral block grafts in critical-sized dog mandible defects: a histological study at the early stages of bone healing.

Bing Du1, Yao Gao2, Yue Deng3, Yadong Zhao4, Chunhua Lai2, Zehong Guo2, Mingdeng Rong2, Lei Zhou2.   

Abstract

Alveolar defects of a critical size cannot heal completely without grafting. Thus, they represent a major clinical challenge to reconstructive surgery. Numerous types of grafts have been used to improve bone regeneration. In the case of particle grafts, the capacity for volume rebuilding and space maintaining is still not ideal, particularly for critical-sized bone defects. Although porous block grafts can overcome the above problems of particle grafts, they are still not widely used for critical-sized alveolar defects, because of their reduced efficacy in blood vessel and bone formation. Thus, in the present study, nano-hydroxyapatite/coralline (nHA/coral) blocks were pre-vascularized by coating them with vascular endothelial growth factor (VEGF), and then implanted in dogs with critical-sized mandibular defects. This model has possible applications in orthopedic and implant surgery. In vivo results indicate that the nHA/coral blocks allow cell and collagen ingrowth because of their suitable pore size and interconnectivity of pores. In addition, pre-vascularization properties were obtained by coating the scaffolds with VEGF. Histological and immunohistochemical examinations, as well as fluorescence analysis, revealed that the local delivery of VEGF can significantly improve neovascularization and mineralization of newly formed bone at the early stages of bone healing in this dog implantation model. Our data collectively show that nHA/coral blocks have possible applications in bone tissue engineering, and excellent results can be achieved by pre-vascularization with VEGF.

Entities:  

Keywords:  Angiogenesis; bone regeneration; histology; tissue engineering

Year:  2015        PMID: 26131067      PMCID: PMC4483881     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  49 in total

1.  The healing of critical-size calvarial bone defects in rat with rhPDGF-BB, BMSCs, and β-TCP scaffolds.

Authors:  Ling Xu; Kaige Lv; Wenjie Zhang; Xiuli Zhang; Xinquan Jiang; Fuqiang Zhang
Journal:  J Mater Sci Mater Med       Date:  2012-02-07       Impact factor: 3.896

2.  Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone.

Authors:  Elias Volkmer; Inga Drosse; Sven Otto; Achim Stangelmayer; Michael Stengele; Bobby Cherian Kallukalam; Wolf Mutschler; Matthias Schieker
Journal:  Tissue Eng Part A       Date:  2008-08       Impact factor: 3.845

3.  The critical-size supraalveolar peri-implant defect model: reproducibility in histometric data acquisition of alveolar bone formation and osseointegration.

Authors:  Jaebum Lee; Quoc Tran; Gary Seeba; Ulf M E Wikesjö; Cristiano Susin
Journal:  J Clin Periodontol       Date:  2009-12       Impact factor: 8.728

4.  Influence of platelet-rich plasma added to xenogeneic bone grafts in periimplant defects: a vital fluorescence study in dogs.

Authors:  Andrés R Sánchez; Phillip J Sheridan; Steven E Eckert; Amy L Weaver
Journal:  Clin Implant Dent Relat Res       Date:  2005       Impact factor: 3.932

5.  In vitro characterizations of mesoporous hydroxyapatite as a controlled release delivery device for VEGF in orthopedic applications.

Authors:  Chye Khoon Poh; Suxiu Ng; Tee Yong Lim; Hark Chuan Tan; Joachim Loo; Wilson Wang
Journal:  J Biomed Mater Res A       Date:  2012-07-24       Impact factor: 4.396

6.  Immunohistochemical study of vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2, -4 (BMP-2, -4) on lengthened rat femurs.

Authors:  Kazumi Sojo; Yoshihiro Sawaki; Hisashi Hattori; Hideki Mizutani; Minoru Ueda
Journal:  J Craniomaxillofac Surg       Date:  2005-08       Impact factor: 2.078

7.  Long-bone critical-size defects treated with tissue-engineered polycaprolactone-co-lactide scaffolds: a pilot study on rats.

Authors:  Claudia Rentsch; Barbe Rentsch; Annette Breier; Kathrin Spekl; Roland Jung; Suzanne Manthey; Dieter Scharnweber; Hans Zwipp; Achim Biewener
Journal:  J Biomed Mater Res A       Date:  2010-12-01       Impact factor: 4.396

8.  Mesenchymal stem cell proliferation and differentiation on an injectable calcium phosphate-chitosan composite scaffold.

Authors:  Jennifer L Moreau; Hockin H K Xu
Journal:  Biomaterials       Date:  2009-02-01       Impact factor: 12.479

9.  The influence of dispersant concentration on the pore morphology of hydroxyapatite ceramics for bone tissue engineering.

Authors:  L A Cyster; D M Grant; S M Howdle; F R A J Rose; D J Irvine; D Freeman; C A Scotchford; K M Shakesheff
Journal:  Biomaterials       Date:  2005-03       Impact factor: 12.479

10.  Use of a collagen membrane loaded with recombinant human bone morphogenetic protein-2 with collagen-binding domain for vertical guided bone regeneration.

Authors:  Chun-Hua Lai; Lei Zhou; Zhong-Lei Wang; Hai-Bin Lu; Yan Gao
Journal:  J Periodontol       Date:  2012-10-22       Impact factor: 6.993

View more
  4 in total

Review 1.  Synthetic and Marine-Derived Porous Scaffolds for Bone Tissue Engineering.

Authors:  Ana S Neto; José M F Ferreira
Journal:  Materials (Basel)       Date:  2018-09-13       Impact factor: 3.623

Review 2.  Current Stage of Marine Ceramic Grafts for 3D Bone Tissue Regeneration.

Authors:  Patricia Diaz-Rodriguez; Miriam López-Álvarez; Julia Serra; Pío González; Mariana Landín
Journal:  Mar Drugs       Date:  2019-08-15       Impact factor: 5.118

Review 3.  Tissue engineering applications in otolaryngology-The state of translation.

Authors:  Weston L Niermeyer; Cole Rodman; Michael M Li; Tendy Chiang
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-06-19

Review 4.  Bone Grafts and Substitutes in Dentistry: A Review of Current Trends and Developments.

Authors:  Rusin Zhao; Ruijia Yang; Paul R Cooper; Zohaib Khurshid; Amin Shavandi; Jithendra Ratnayake
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.